Literature DB >> 16343638

Aerobic capacity, oxidant stress, and chronic obstructive pulmonary disease--a new take on an old hypothesis.

Christopher S Stevenson1, Lauren Gerard Koch, Steven L Britton.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a smoking-related disorder that is a leading cause of death worldwide. It is associated with an accelerated rate of age-related decline in lung function due to the occurrence of destructive pathological changes such as emphysema, small airway remodeling, and mucus hypersecretion. Smokers are exposed to trillions of radicals and thousands of reactive chemicals and particles with every cigarette, thus oxidant stress is believed to be a central factor in the pathogenesis of COPD. The molecular activities of radicals, reactive oxygen, and nitrogen species can, over time, lead to a number of the detrimental changes in the lung. For instance, smoke can directly damage the mitochondrion, an organelle that has long been linked to age-related diseases associated with oxidant stress. Mitochondria are involved in a number of important cellular processes and are the largest source of endogenous reactive oxygen species (ROS) in the cell; therefore, any impairment of mitochondrial function can lead to greater oxidant damage, cellular dysfunction, and eventually to disease. Only a subset of smokers (15-50%) develops COPD, suggesting that there are polygenetic and/or environmental susceptibility factors involved in this complex disease. Here, we propose that the aerobic capacity for an individual may determine whether one is susceptible to developing COPD. Aerobic capacity is a polygenetic trait closely associated with mitochondrial function, and we suggest antioxidant defenses. Thus, those smokers who have the greatest aerobic capacity will be most resistant to the effects of chronic cigarette smoke exposure and be less likely to develop COPD.

Entities:  

Mesh:

Year:  2005        PMID: 16343638     DOI: 10.1016/j.pharmthera.2005.09.006

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  11 in total

1.  Longevity-associated mitochondrial DNA 5178 C/A polymorphism and its interaction with cigarette consumption are associated with pulmonary function in middle-aged Japanese men.

Authors:  Akatsuki Kokaze; Mamoru Ishikawa; Naomi Matsunaga; Masao Yoshida; Masao Satoh; Koji Teruya; Rie Honmyo; Takako Shirasawa; Hiromi Hoshino; Yutaka Takashima
Journal:  J Hum Genet       Date:  2007-07-17       Impact factor: 3.172

2.  Genetic and environmental influence on lung function impairment in Swedish twins.

Authors:  Jenny Hallberg; Anastasia Iliadou; Martin Anderson; Maria Gerhardsson de Verdier; Ulf Nihlén; Magnus Dahlbäck; Nancy L Pedersen; Tim Higenbottam; Magnus Svartengren
Journal:  Respir Res       Date:  2010-07-06

Review 3.  More to Explore: Further Definition of Risk Factors for COPD - Differential Gender Difference, Modest Elevation in PM2.5, and e-Cigarette Use.

Authors:  Yixuan Zhang; Lu Wang; Gökhan M Mutlu; Hua Cai
Journal:  Front Physiol       Date:  2021-05-05       Impact factor: 4.566

4.  Changes in six-minute walking distance during pulmonary rehabilitation in patients with COPD and in healthy subjects.

Authors:  Imen Ben Cheikh Rejbi; Yassine Trabelsi; Afef Chouchene; Wafa Ben Turkia; Helmi Ben Saad; Abdelkarim Zbidi; Abdelhamid Kerken; Zouhair Tabka
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-08-09

Review 5.  New Insights into the Implication of Mitochondrial Dysfunction in Tissue, Peripheral Blood Mononuclear Cells, and Platelets during Lung Diseases.

Authors:  Marianne Riou; Abrar Alfatni; Anne-Laure Charles; Emmanuel Andrès; Cristina Pistea; Anne Charloux; Bernard Geny
Journal:  J Clin Med       Date:  2020-04-26       Impact factor: 4.241

6.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

7.  Effect of early treatment with transcutaneous electrical diaphragmatic stimulation (TEDS) on pulmonary inflammation induced by bleomycin.

Authors:  Laisa A Santos; Carlos A Silva; Maria L O Polacow
Journal:  Braz J Phys Ther       Date:  2013-11-14       Impact factor: 3.377

8.  Physical exercise is effective in preventing cigarette smoke-induced pulmonary oxidative response in mice.

Authors:  Renata Tiscoski Nesi; Priscila Soares de Souza; Giulia Pedroso Dos Santos; Anand Thirupathi; Bruno T Menegali; Paulo Cesar Lock Silveira; Luciano Acordi da Silva; Samuel Santos Valença; Ricardo Aurino Pinho
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-03-22

9.  In vitro evaluation of antioxidant activities of aqueous extracts from natural and cultured mycelia of Cordyceps sinensis.

Authors:  C-H Dong; Y-J Yao
Journal:  Lebensm Wiss Technol       Date:  2007-05-13       Impact factor: 4.952

10.  Correlation between sestrin2 expression and airway remodeling in COPD.

Authors:  Da-Wei Zhang; Yuan-Yuan Wei; Shuang Ji; Guang-He Fei
Journal:  BMC Pulm Med       Date:  2020-11-16       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.